Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Diacerein in the Metabolic Control of Patients With Diabetes Mellitus Type 2 and Secondary Failure to Metformin

NCT03208309 is registered in ClinicalTrials.gov with ANS Pharma as lead sponsor.

NCT NCT03208309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Diacerein in the Metabolic Control of Patients With Diabetes Mellitus Type 2 and Secondary Failure to Metformin
Lead sponsor
ANS Pharma
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2015
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

complications of diabetes mellitus, diabetes mellitus, diabetes mellitus, type 2